Skip to content

Examining the feasibility of implementing of an evidence-based Frailty Response Program in hospital settings for frail adults with aortic stenosis undergoing heart valve replacement procedures (FRAIL-AS Response Trial)

Frailty response in patients with aortic stenosis undergoing transcatheter aortic valve implantation: a pilot, cluster randomised controlled trial (FRAIL-AS Response Trial)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000318583
Acronym
FRAIL-AS Response Trial
Enrollment
250
Registered
2024-03-25
Start date
2024-09-13
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Frailty is present in 3 out of 10 people who undergo TAVI. However, there's limited evidence for managing frailty, which worsens outcomes in patients post TAVI. This trial aims to assess the feasibility of implementing a tailored Frailty Response Program for frail aortic stenosis patients undergoing TAVI. Using a cluster randomised controlled trial design, it will compare this program to standard care in hospitals. The multicomponent program (nutrition, patient information, GP notification, geriatric assessment and rehabilitation) adjusted to the patient's frailty status, will commence pre-TAVI and patients will be followed up for 12-months post procedures. This project aims to determine the impact of evidence-based frailty management on aortic stenosis patient outcomes post TAVI.

Interventions

The Frailty Response Clinical Protocol This will be delivered by structural heart team clinicians and is comprised of five evidence-based components tailored to patients frailty classification (mild, moderate or severe), it involves: i) nutritional assessment: each hospital may use an existing a validated questionnaire such as the commonly used Malnutrition Screening Tool - MST (estimated 10 minutes to complete), conducted with the patient (either via telephone or in-person) by the hospital cl

The Frailty Response Clinical Protocol This will be delivered by structural heart team clinicians and is comprised of five evidence-based components tailored to patients frailty classification (mild, moderate or severe), it involves: i) nutritional assessment: each hospital may use an existing a validated questionnaire such as the commonly used Malnutrition Screening Tool - MST (estimated 10 minutes to complete), conducted with the patient (either via telephone or in-person) by the hospital clinicians prior to TAVI ii) patient frailty information; provision of written information to patients describing what frailty is and how patients can recognise it and how to manage it, either before or post TAVI. Using existing hospital resources or publicly available resources such as the British Geriatric Society ‘What is Frailty’ information sheet. iii) general practitioner notification of patient frailty; correspondence sent from the clinicians to the patients GP notifying them that the patient has been identified as being frail v) referral for cardiac rehabilitation; after undergoing a TAVI procedure, aligned with routine care, patients will be referred by hospital clinicians to a cardiac rehabilitation program iv) referral for geriatric assessment (moderate and severe frailty only), prior or within 3 months after the TAVI procedure, a referral from the hospital clinicians to a geriatrician requesting the patient undergo a comprehensive geriatric assessment The Frailty Response Program Implementation Strategy The following evidence-based approaches and strategies for changing clinician behaviours will be used to implement the intervention, they will be commenced post randomisation and expected to be conducted for up to 3 months prior to prospective data collection: i) Use of local clinical champions (hospital clinical champions) identified at the start of the trial at each site. Nursing and medical clinical champions will be identified from each transcatheter aortic valve implantation (TAVI) clinical team to support conduct of the trial and implementation of the intervention. Activities may include active engagement with the research team, raising awareness of the trial and implementation of the intervention at site amongst broader clinical colleagues, working with the research teams to identify local solutions to embed the intervention and assisting with trial data collection alongside the research team. ii) Frailty Response Clinical Protocol education. To enable compliance with implementation of the Frailty Response Clinical Protocol training will be provided by the research team and relevant clinical experts. The education session is anticipated to run for 1 hour, with an overview of the trial and question and answer session. iii) Barriers and enablers meeting. A meeting on barriers and enablers will be conducted at each intervention hospital, involving the local TAVI clinical teams and other relevant personnel. The meeting aims to identify local barriers, enablers, and potential solutions to facilitate the implementation of the Frailty Response Program intervention in TAVI clinical programs. The barriers and enablers meeting is anticipated to run for 1 hour, and will be facilitated by a member of the research team. Following the meeting, action plans will be devised with the local clinical champion and the researchers, and any required local adjustments for the effective implementation of the Frailty Response Clinical Protocol will be discussed and included. iv) Frailty education session. The session is expected to run for 1hr and will be delivered by the research team and relevant clinical experts for TAVI clinical teams. The aim is to enhance awareness and understanding of frailty, emphasising measurement using the validated Clinical Frailty Scale. v) External Remote Facilitation. The researchers will provide external remote facilitation to intervention hospitals. Their role will involve providing information about the Frailty Response Program intervention to participating hospitals and granting intervention hospitals access to the frailty education session (recorded, emailed upon request to clinical champion). vi) Clinical processes of care audit and feedback report. Clinical champions in intervention hospitals will receive a baseline report of their pre-implementation clinical processes of care audit data highlighting compliance with the Frailty Response Clinical Protocol prior to the intervention. Process evaluation Clinicians from selected intervention hospitals, stratified by (1) hospital type (private or public) and (2) performance status (high and low performing, determined by final trial results on Frailty Response Clinical Protocol compliance), will be invited to participate in focus groups and semi-structured interviews. Clinical champions from the respective hospitals will facilitate engagement. The process evaluation aims to explore organisational, contextual, and structural factors influencing the successful or unsuccessful adoption of the intervention.

Sponsors

Australian Catholic University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Subject)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Hospitals To be eligible to participate in the trial, hospitals must: • have a TAVI clinical program (or equivalent) that is anticipated to perform = 50 TAVI procedures per year • be currently collecting routine patient data for the Australasian Cardiac Outcomes Registry (ACOR) - TAVI Registry. Patients within eligible hospitals will be included if: • they are aged 18 years or older. • have a diagnosis of aortic stenosis and have been scheduled to undergoing a TAVI procedure. • have been routinely identified as being frail (a score of mild-5, moderate-6, severe-7 on the scale) using the Clinical Frailty Scale (CFS).

Exclusion criteria

Hosptials who do not have a TAVI clinical program (or equivalent) anticipated to perform more than 50 TAVI procedures per year.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026